KRYSTAL BIOTECH INC. - COMMON STOCK
164.10
17-May-24 15:59:59
15 minutes delayed
Stocks
+0.32
+0.20%
Today's range
160.95 - 164.38
ISIN
N/A
Source
NASDAQ
-
Krystal Biotech to Present at 2022 American Academy of Dermatology Annual Meeting
18 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
Krystal Biotech Announces Settlement with PeriphaGen, Inc.
15 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech to Participate in Cowen’s 42nd Annual Health Care Conference
24 Feb 2022 07:00:03 By Nasdaq GlobeNewswire
-
18 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
30 Nov 2021 20:15:00 By Nasdaq GlobeNewswire
-
Krystal Biotech Announces Proposed $200 Million Public Offering of Common Stock
29 Nov 2021 16:20:00 By Nasdaq GlobeNewswire
-
29 Nov 2021 07:00:00 By Nasdaq GlobeNewswire
-
08 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
26 Oct 2021 07:00:00 By Nasdaq GlobeNewswire
-
19 Oct 2021 16:05:00 By Nasdaq GlobeNewswire
-
14 Oct 2021 07:00:00 By Nasdaq GlobeNewswire
-
12 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
Krystal Biotech to Present at the Chardan 5th Annual Genetic Medicines Conference
01 Oct 2021 16:01:00 By Nasdaq GlobeNewswire
-
29 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech Appoints Laurent Goux as General Manager of Europe
15 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech to Present Data on DEB and B-VEC at the DEBRA International Conference 2021
09 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
Krystal Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep 2021 16:31:00 By Nasdaq GlobeNewswire
-
09 Aug 2021 08:00:01 By Nasdaq GlobeNewswire
-
01 Jul 2021 16:15:00 By Nasdaq GlobeNewswire
-
Krystal Biotech to Participate in Upcoming Investor Conferences
03 Jun 2021 08:00:00 By Nasdaq GlobeNewswire